Subnet Session with Michaela Bazo, CEO of Metanova: Rewiring Drug Discovery with SN68
Revenue Search: Inside Bittensor
00:00
How Metanova simulates binding and expands properties
Michaela describes using open-source models to predict molecule binding, plans to add properties like blood-brain barrier crossing, and the complexity of targets.
Play episode from 05:20
Transcript
